Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spark

Showing results (321-330 of 331) with videos related to

Pageof 34
Sort By:
The Australasian Journal of Dermatology|April 24, 2023
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual with respect to 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseMartelle Coetzer-Botha, Clara Jimenez Balcells, Jeremy Hay, et al.
The Australasian Journal of Dermatology|August 23, 2021
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseClara Jimenez Balcells, Jeremy Hay, Jeff Keir, et al.
The Australasian Journal of Dermatology|April 19, 2022
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseJeremy Hay, Jeff Keir, Clara Jimenez Balcells, et al.
Schizophrenia Bulletin|December 20, 2024
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk IndividualsCassandra Wannan, Isabelle Scott, Dominic Dwyer, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine EffectivenessAlexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.
Schizophrenia (Heidelberg, Germany)|March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sampleKelly Allott, Walid Yassin, Luis Alameda, et al.
Pageof 34

Showing results (321-330 of 331) with videos related to

Sort By:
Pageof 34
The Australasian Journal of Dermatology|April 24, 2023
Practitioner characteristics, diagnostic accuracy metrics and discovering-individual with respect to 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseMartelle Coetzer-Botha, Clara Jimenez Balcells, Jeremy Hay, et al.
The Australasian Journal of Dermatology|August 23, 2021
Characteristics of 637 melanomas documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseClara Jimenez Balcells, Jeremy Hay, Jeff Keir, et al.
The Australasian Journal of Dermatology|April 19, 2022
Characteristics, treatment and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research DatabaseJeremy Hay, Jeff Keir, Clara Jimenez Balcells, et al.
Schizophrenia Bulletin|December 20, 2024
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk IndividualsCassandra Wannan, Isabelle Scott, Dominic Dwyer, et al.
Early Intervention in Psychiatry|July 1, 2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for PsychosisDulari Hakamuwa Lekamlage, Ling Min Amelia Ang, Luba Sominsky, et al.
Influenza and Other Respiratory Viruses|March 17, 2024
Risk of COVID-19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric DisordersMatthew E Levy, Duck-Hye Yang, Margaret M Dunne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine EffectivenessAlexandra F Dalton, Zachary A Weber, Katie S Allen, et al.
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
Schizophrenia (Heidelberg, Germany)|April 3, 2025
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia ProgramTashrif Billah, Kang Ik K Cho, Owen Borders, et al.
Schizophrenia (Heidelberg, Germany)|March 25, 2025
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sampleKelly Allott, Walid Yassin, Luis Alameda, et al.
Pageof 34